SAMHD1, positively regulated by KLF4, suppresses the proliferation of gastric cancer cells through MAPK p38 signaling pathway

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Japanese Gastric Cancer A. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer. 2021;24(1):1–21.
   PubMed Web of Science ®Google Scholar
• Al-Batran SE, Homann N, Pauligk C, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet. 2019;393(10184):1948–1957.
   PubMed Web of Science ®Google Scholar
• Schuhmacher C, Gretschel S, Lordick F, et al. Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European organisation for research and treatment of cancer randomized trial 40954. J Clin Oncol. 2010;28(35):5210–5218.
   PubMed Web of Science ®Google Scholar
• Zeng H, Chen W, Zheng R, et al. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries. Lancet Glob Health. 2018;6(5):e555–e67.
   PubMed Web of Science ®Google Scholar
• Van Cutsem E, Bang YJ, Feng-Yi F, et al. HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer. Gastric Cancer. 2015;18(3):476–484.
   PubMed Web of Science ®Google Scholar
• Goldstone DC, Ennis-Adeniran V, Hedden JJ, et al. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature. 2011;480(7377):379–382.
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhu M, Pan X, et al. Inhibition of hepatitis B virus replication by SAMHD1. Biochem Biophys Res Commun. 2014;450(4):1462–1468.
   PubMedGoogle Scholar
• Park K, Ryoo J, Jeong H, et al. Aicardi-Goutieres syndrome-associated gene SAMHD1 preserves genome integrity by preventing R-loop formation at transcription-replication conflict regions. PLoS Genet. 2021;17(4):e1009523.
   PubMedGoogle Scholar
• Franzolin E, Coletta S, Ferraro P, et al. SAMHD1-deficient fibroblasts from aicardi-goutieres syndrome patients can escape senescence and accumulate mutations. FASEB J. 2020;34(1):631–647.
   PubMedGoogle Scholar
• Rice GI, Bond J, Asipu A, et al. Mutations involved in aicardi-goutieres syndrome implicate SAMHD1 as regulator of the innate immune response. Nat Genet. 2009;41(7):829–832.
   PubMedGoogle Scholar
• Wang JL, Lu FZ, Shen XY, et al. SAMHD1 is down regulated in lung cancer by methylation and inhibits tumor cell proliferation. Biochem Biophys Res Commun. 2014;455(3–4):229–233.
   PubMed Web of Science ®Google Scholar
• Wu Y, Niu Y, Wu Y, et al. SAMHD1 can suppress lung adenocarcinoma progression through the negative regulation of STING. J Thorac Dis. 2021;13(1):189–201.
   PubMedGoogle Scholar
• Kodigepalli KM, Li M, Liu SL, et al. Exogenous expression of SAMHD1 inhibits proliferation and induces apoptosis in cutaneous T-cell lymphoma-derived HuT78 cells. Cell Cycle. 2017;16(2):179–188.
   PubMed Web of Science ®Google Scholar
• de Silva S, Wang F, Hake TS, et al. Downregulation of SAMHD1 expression correlates with promoter DNA methylation in sezary syndrome patients. J Invest Dermatol. 2014;134(2):562–565.
   PubMed Web of Science ®Google Scholar
• Kohnken R, Kodigepalli KM, Mishra A, et al. MicroRNA-181 contributes to downregulation of SAMHD1 expression in CD4+ T-cells derived from sezary syndrome patients. Leuk Res. 2017;52:58–66.
   PubMed Web of Science ®Google Scholar
• World Medical A. World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–2194.
   PubMed Web of Science ®Google Scholar
• Meng L, Chen Z, Jiang Z, et al. MiR-122-5p suppresses the proliferation, migration, and invasion of gastric cancer cells by targeting LYN. Acta Biochim Biophys Sin (Shanghai). 2020;52(1):49–57.
   PubMed Web of Science ®Google Scholar
• Chen ZM, Huang L, Li MM, et al. Inhibitory effects of isocryptotanshinone on gastric cancer. Sci Rep. 2018;8(1):9307.
   PubMedGoogle Scholar
• Kodigepalli KM, Bonifati S, Tirumuru N, et al. SAMHD1 modulates in vitro proliferation of acute myeloid leukemia-derived THP-1 cells through the PI3K-Akt-p27 axis. Cell Cycle. 2018;17(9):1124–1137.
   PubMed Web of Science ®Google Scholar
• Yue J, Lopez JM. Understanding MAPK signaling pathways in apoptosis. Int J Mol Sci. 2020;21(7):2346.
   PubMed Web of Science ®Google Scholar
• Kumar GS, Page R, Peti W. The interaction of p38 with its upstream kinase MKK6. Protein Sci. 2021;30(4):908–913.
   PubMedGoogle Scholar
• He D, Wu H, Xiang J, et al. Gut stem cell aging is driven by mTORC1 via a p38 MAPK-p53 pathway. Nat Commun. 2020;11(1):37.
   PubMedGoogle Scholar
• Clifford R, Louis T, Robbe P, et al. SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage. Blood. 2014;123(7):1021–1031.
   PubMed Web of Science ®Google Scholar
• Kodigepalli KM, Li M, Bonifati S, et al. SAMHD1 inhibits epithelial cell transformation in vitro and affects leukemia development in xenograft mice. Cell Cycle. 2018;17(23):2564–2576.
   PubMed Web of Science ®Google Scholar
• Fang Y, Yang J, Zu G, et al. Junctional adhesion molecule-like protein promotes tumor progression and metastasis via p38 signaling pathway in gastric cancer. Front Oncol. 2021;11:565676.
   PubMedGoogle Scholar
• Huang N, Cui X, Li W, et al. IL33/ST2 promotes the malignant progression of gastric cancer via the MAPK pathway. Mol Med Rep. 2021;23(5):361.
   PubMedGoogle Scholar
• Chen W, Cheng P, Jiang J, et al. Epigenomic and genomic analysis of transcriptome modulation in skin cutaneous melanoma. Aging (Albany NY). 2020;12(13):12703–12725.
   PubMedGoogle Scholar
• Valverde-Estrella L, Lopez-Serrat M, Sanchez-Sanchez G, et al. Induction of Samhd1 by interferon gamma and lipopolysaccharide in murine macrophages requires IRF1. Eur J Immunol. 2020;50(9):1321–1334.
   PubMedGoogle Scholar
• Zhang J, Zhu Z, Wu H, et al. PODXL, negatively regulated by KLF4, promotes the EMT and metastasis and serves as a novel prognostic indicator of gastric cancer. Gastric Cancer. 2019;22(1):48–59.
   PubMedGoogle Scholar
• Li JC, Chen QH, Jian R, et al. The partial role of KLF4 and KLF5 in gastrointestinal tumors. Gastroenterol Res Pract. 2021;2021:2425356.
   PubMedGoogle Scholar
• Taracha-Wisniewska A, Kotarba G, Dworkin S, et al. Recent discoveries on the involvement of kruppel-like factor 4 in the most common cancer types. Int J Mol Sci. 2020;21(22):8843.
   Google Scholar
• Kong F, Sun T, Kong X, et al. Kruppel-like factor 4 suppresses serine/threonine kinase 33 activation and metastasis of gastric cancer through reversing epithelial-mesenchymal transition. Clin Cancer Res. 2018;24(10):2440–2451.
   PubMedGoogle Scholar
• Liu Z, Wu X, Tian Y, et al. H. pylori infection induces CXCL8 expression and promotes gastric cancer progress through downregulating KLF4. Mol Carcinog. 2021;60(8):524–537.
   PubMedGoogle Scholar
• Chen BJ, Zeng S, Xie R, et al. hTERT promotes gastric intestinal metaplasia by upregulating CDX2 via NF-kappaB signaling pathway. Oncotarget. 2017;8(16):26969–26978.
   PubMedGoogle Scholar
• Lee HJ, Kang YM, Moon CS, et al. KLF4 positively regulates human ghrelin expression. Biochem J. 2009;420(3):403–411.
   PubMedGoogle Scholar
• Zhu M, Zhang N, He S. Transcription factor KLF4 modulates microRNA-106a that targets Smad7 in gastric cancer. Pathol Res Pract. 2019;215(8):152467.
   PubMed Web of Science ®Google Scholar
• Zhu M, Zhang N, Lu X, et al. Negative regulation of kruppel-like factor 4 on microRNA-106a at upstream transcriptional level and the role in gastric cancer metastasis. Dig Dis Sci. 2018;63(10):2604–2616.
   PubMedGoogle Scholar
• Wang L, Li Y, Li L, et al. Role of Kruppel-like factor 4 in regulating inhibitor of apoptosis-stimulating protein of p53 in the progression of gastric cancer. Oncol Lett. 2018;15(5):6865–6872.
   PubMedGoogle Scholar
• Zhao R, Liu Z, Xu W, et al. Helicobacter pylori infection leads to KLF4 inactivation in gastric cancer through a TET1-mediated DNA methylation mechanism. Cancer Med. 2020;9(7):2551–2563.
   PubMed Web of Science ®Google Scholar
• Ou Y, Ren H, Zhao R, et al. Helicobacter pylori CagA promotes the malignant transformation of gastric mucosal epithelial cells through the dysregulation of the miR-155/KLF4 signaling pathway. Mol Carcinog. 2019;58(8):1427–1437.
   PubMedGoogle Scholar
• Banchenko S, Krupp F, Gotthold C, et al. Structural insights into Cullin4-RING ubiquitin ligase remodelling by Vpr from simian immunodeficiency viruses. PLoS Pathog. 2021;17(8):e1009775.
   PubMedGoogle Scholar
• Cingoz O, Arnow ND, Puig Torrents M, et al. Vpx enhances innate immune responses independently of SAMHD1 during HIV-1 infection. Retrovirology. 2021;18(1):4.
   PubMedGoogle Scholar
• Zhang K, Dongwen L, Li R. Conserved herpesvirus protein kinases target SAMHD1 to facilitate virus replication. Cell Rep. 2019;28(2):449–59 e5.
   PubMedGoogle Scholar